Ascend Gene & Cell Therapies
UKAscend Gene & Cell Therapies is a biotech company, headquartered in UK.
Entry
2023
Hold
3yr
Status
Active
Est. EV
–
Key facts
HQUK
SectorBiotech
StatusActive
UK gene and cell therapy manufacturing specialist; Abingworth co-led its 2023 launch Series A financing.
See the full ownership history.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Full fund context: vintage, strategy, region
Already a member? Sign in
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceLast updated May 2026 · Sourced from public filings
Denmark